Valeria Croce, Partner and Italian and European Patent Attorney at Jacobacci & Partners, explains in this video her collaboration with L’Istituto Oncologico Veneto. It is indeed of decisive importance, for this center of excellence in the treatment of oncological patients, to protect through patents the new discoveries made in the field of medical-pharmacological experimentation aimed at finding new treatments to improve the lives of patients. These patents, according to Dr. Patrizia Benini, Director General of the Veneto Oncology Institute, reflect the commitment, expertise and strategic vision of this cutting-edge research institute. Also speaking are Prof. Antonio Rosato, Director of the UOC Immunology and Molecular Oncology Diagnostics, who tells about the Adjuvant project, and Prof. Stefano Indraccolo, Head of the UOSD Basic Experimental and Translational Oncology, who presents the Notch3 patent and the Regoma patent.